Ortin Laboratories

quarterly
yearly
ParticularsJun '21Sep '21Dec '21Mar '22Jun '22
Revenue1.982.291.662.292.62
Expenses1.692.071.572.812.49
EBITDA0.290.220.09-0.520.13
EBIT0.220.150.09-0.750.06
Profit Before Tax0.120.07-0.11-0.600.03
Net Profit0.090.05-0.09-0.45-0.43
Financial Ratios
Operating Profit Margin15.15%9.61%4.82%-22.71%4.96%
Net Profit Margin4.55%2.18%-5.42%-19.65%-16.41%
Earning Per Share (Diluted)0.110.07-0.11-0.50-0.52
Dividends Per ShareNANANANANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.3.6
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI